Clinical Trial Update: Precutaneous High Risk Patent Foramen Ovale to Treat Migraine Headaches [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating percutaneous closure of patent foramen ovale to treat migraine headaches; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Patent Foramen Ovale

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Patent Foramen Ovale | Phase 2 | Status: UNKNOWN